US FDA approves first RSV vaccine from GSK

The approval makes GSK, which has been neck-and-neck with Pfizer in RSV vaccine development, the first company to tap into a multi-billion-dollar market and puts it ahead of rivals such as Moderna Inc and Bavarian Nordic .

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/4ZDjYUh
via IFTTT